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Abstract 
Elevating the technical role of pharmacy technicians to perform Technician Product Verification (TPV) is one strategy that has shown 
promise to optimize pharmacy practice models. This is done by better positioning pharmacists to provide clinical care, in line with their 
education and expertise. TPV permits a Validated Pharmacy Technician, as defined by the Wisconsin Pharmacy Examining Board, to 
verify the accuracy of a product filled by another technician. The pharmacist maintains responsibility for assessing the clinical 
appropriateness of the prescription, including drug utilization review, data entry, and patient counseling. 
 
During the study period, 12,891 pharmacist-verified prescriptions (baseline) and 27,447 Validated Pharmacy Technician-verified 
prescriptions were audited for accuracy. The aggregate verification error rate for pharmacist-verified prescriptions was 0.16% and 
0.01% for Validated Pharmacy Technician-verified prescriptions. The mean error rate was significantly less for Validated Pharmacy 
Technician-verified prescriptions than for pharmacist-verified prescriptions (0.19 ± 0.174 % vs 0.03 ± 0.089 %, p=0.020) (Figure 3).  
 
This suggests TPV in the community pharmacy setting maintained patient safety. In this study, Validated Pharmacy Technicians were 
shown to be more accurate than pharmacists at performing product verification. The ability to delegate the product verification task 
holds the potential to free up pharmacist time for increased direct patient care. Increasing direct patient care by pharmacists in 
community pharmacies may have significant implications for improving patient outcomes and pharmacy quality. 
 
 
Keywords: Technician Product Verification; Product Verification; Delegate-Check-Delegate; Tech-Check-Tech; Optimizing Care; 
Pharmacy Care; Community Pharmacy; Pharmacy Technician 
 
 
Introduction 
The need for widespread delivery of patient care services at 
community pharmacies is growing. In the context of a predicted 
physician shortage1 and an aging population with increased 
prevalence of chronic conditions and medication use,2 
community pharmacists are poised and qualified to support 
enhanced clinical care for patients. Pharmacists are in a position 
to support and expand patient care services, evolving the 
community pharmacy practice model to improve patient-care, 
as 91% of Americans live within five miles of a community 
pharmacy.3 In order for community pharmacies to feasibly offer 
clinical care more broadly and meet the needs of patients, 
current practice models must be adapted to optimize patient 
care. 
  
Elevating the technical role of pharmacy technicians to perform 
Technician Product Verification (TPV) is one strategy that has 
shown promise to optimize pharmacy practice models by better 
positioning pharmacists to provide clinical care, in line with 
their education and expertise. TPV permits a trained and 
validated pharmacy technician, known as a Validated Pharmacy  
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Technician, to verify the accuracy of a product filled by another 
technician, while the pharmacist maintains responsibility for 
assessing the clinical appropriateness of all prescriptions. “Final 
product verification” historically has been completed by a 
pharmacist, as required by state law, however, the time a 
pharmacist spends completing product verification can be 
substantial.4 By permitting trained and qualified pharmacy 
technicians to complete this technical task, pharmacists can 
redirect more time and attention toward direct patient care.  
 
Past Research 
Research suggests that pharmacists spend a substantial amount 
of time performing product verification and trained pharmacy 
technicians can perform the same task with similar accuracy 
rates to pharmacists. A study conducted by Reed et al. (2011) 
in an academic medical center hospital observed the time 
pharmacists spent on product verification decreased by 94.5% 
when technician product verification was initiated.5 Tarver et 
al. (2017) studied the impacts of technician product verification 
on automated medication supply systems in an academic 
medical center. The study demonstrated a significant decrease 
in the time pharmacists spent on product verifications for the 
total automated medication supply system, STAT medication 
orders, and routine orders.6 In a 1991 study conducted by 
Woller et al., pharmacy technicians who completed didactic 
and practical training completed the product verification of unit 
dose carts with artificial errors and were at least 99.94% 
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accurate.7 Additional studies that followed8,9,10,11 showed 
pharmacy technicians and pharmacists perform product 
verifications with similar accuracy.  
 
While compelling, the majority of previous research has 
focused on technician product verification in the inpatient or 
institutional setting. Iowa’s New Practice Model pilot program 
was the first statewide pilot of community setting-based 
technician product verification in the country. This concept 
study by Andreski et al. confirmed that TPV can be 
implemented safely in the community pharmacy setting, 
replicating findings from inpatient practice. The study piloted 
TPV, with an emphasis on redirecting pharmacist time to 
patient care, in seven pharmacies over 18 months. During this 
time, there was no significant difference in product verification 
overall errors (0.2729% vs. 0.5124%, P = 0.513), patient safety 
errors (0.0525% vs. 0.0651%, P = 0.837) or administrative errors 
(0.2204% vs. 0.4784%, P=0.411) when product verification was 
completed by pharmacists versus pharmacy technicians. The 
New Practice Model study also evaluated how pharmacists 
spent their time prior to and post-implementation of technician 
product verification. Pharmacist time spent on dispensing, 
including completing the product verification, decreased 
significantly (67.3% vs. 49.06%) while direct patient care 
increased significantly (19.96% vs. 34.72%, P=0.003).12 
 
Further, the University of Wisconsin Health completed a 
feasibility study in a mail order and health-system outpatient 
pharmacy. The four-week study analyzed the accuracy of a 
pharmacy technician at completing the product verification as 
audited by a pharmacist. It was determined technicians were as 
accurate as pharmacists at completing product verification 
(99.95% vs. 99.74%), and the new workflow permitted the 
pharmacist in the outpatient pharmacy to have a projected 
additional 23 days per year worth of pharmacist time to spend 
on direct patient care.13 
 
Given the successes of the Iowa pilot study and a Wisconsin 
health system feasibility study, a second pilot study was 
initiated in Wisconsin to assess the effects of technician product 
verification on patient safety and pharmacy practice in the 
community setting. This community setting pilot sought to 
demonstrate the replicability of Iowa’s initial pilot findings in 
another context to potentially support broader replicability of 
the model across the country. 
 
Wisconsin Pilot Authority 
Wisconsin statute 450.02(3r) allows the Wisconsin Pharmacy 
Examining Board to authorize pilot programs related to 
pharmacy or prescription verification, or pilots that will 
improve the safety, quality, or efficiency of the practice of 
pharmacy in Wisconsin for up to three years.14 Such 
permissions include waiving statutes, such as the requirement 
for pharmacists to complete product verification. 
 
 
Objective 
Assess the impact of technician product verification in 
community pharmacies in Wisconsin on patient safety 
measures and on facilitating community pharmacist-provided 
services. 
 
Methods 
Study Design 
The study design was a single group, pre-test – post-test 
comparison using t testing. Data was self-reported in aggregate 
for the pharmacy, not by individual pharmacists or Validated 
Pharmacy Technicians. Therefore, the unit of analysis was the 
pharmacy, not individual pharmacists or Validated Pharmacy 
Technicians.  
 
In all phases of data collection, individual data was aggregated 
and de-identified by each pharmacy before being submitted to 
Concordia University Wisconsin School of Pharmacy via 
Qualtrics Survey Hosting Service. 
 
The Wisconsin TPV pilot was approved by the Pharmacy 
Examining Board from November 1, 2016- October 1, 2019, and 
the study period and data collection ran from January 1, 2017, 
to December 31, 2017. 
 
Pharmacy Requirements 
In order to participate in the Wisconsin TPV pilot, the pharmacy 
had to comply with Wisconsin Pharmacy Examining Board 
requirements, including:15 
 
 A pharmacist assessed the clinical appropriateness and 
provided consultation to a patient on each prescription 
dispensed at the pharmacy. This statutory and 
regulatory requirement in Wisconsin preceded the 
study and exists independently from the TPV pilot. 
 The pharmacy implemented TPV quality assurance 
measures that were added to the pharmacy’s 
preexisting quality assurance plan, in accordance with 
the pilot requirements. 
 Validated Pharmacy Technicians were permitted to 
complete the product verification of any non-
compounded, non-reconstituted, non-mailed, and non-
delivered prescription. However, if a prescription 
encountered a technology override (e.g., National Drug 
Code change), the product verification could not be 
completed by a Validated Pharmacy Technician. 
 Implementation of TPV was not intended to reduce 
pharmacist staffing levels but was intended to increase 
the availability of a pharmacist for involvement in other 
patient care activities. In the pharmacy application, the 
pharmacy attested to the Wisconsin Pharmacy 
Examining Board that the pilot was to “be utilized to 
provide direct patient care services and is not intended 
to reduce staffing levels.”16 
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 Prior to completing product verification independently, 
Validated Pharmacy Technicians completed didactic 
training and practical training in accordance with 
curriculum components required by the Wisconsin 
Pharmacy Examining Board and developed by the 
Pharmacy Society of Wisconsin. All Validated Pharmacy 
Technicians were required to achieve at least an 
accuracy rate of 99.8% after completing the product 
verification of 1,000 prescriptions that were audited by 
a pharmacist.17 Prior studies evaluating TPV have also 
implemented requirements for training and/or 
validation.18,19,20  
 
Pharmacy Recruitment 
Participating pharmacies were identified and selected based on 
their prior exemplary record of performing enhanced 
pharmacist-provided patient care services, signifying their 
ability to expand these services upon technician product 
verification implementation. Many of the inquiries for 
participation in the pilot were identified through the Pharmacy 
Society of Wisconsin’s Wisconsin Pharmacy Quality 
Collaborative, a network of accredited, high-quality pharmacies 
with trained and certified pharmacists who provide medication 
therapy management services to patients with chronic 
conditions, complex medication regimens, or low health 
literacy.21  
 
The study team contacted four chain pharmacy organizations, 
six health-systems, and eleven independent organizations to 
inquire about their interest in having up to three of their 
pharmacies participate in the pilot. In total, 16 pharmacies from 
three chain pharmacy organizations, four health-system 
organizations, and three independent pharmacies 
organizations elected to participate in the pilot.  
 
Procedures 
Assess Effect of TPV on Patient Safety 
The impact of technician product verification on patient safety 
was assessed by comparing the accuracy of Validated Pharmacy 
Technicians’ completing the product verification of a 
prescription to the accuracy of a pharmacist completing the 
product verification of a prescription. 
 
To establish baseline, the accuracy of participating pharmacists 
at completing the product verification was determined. A 
prescription was filled by a pharmacy technician, product 
verified by a pharmacist, and product verified for a second time 
by a different pharmacist, pharmacist intern, or Validated 
Pharmacy Technician. Data was collected on baseline product 
verification errors including incorrect drug, dose, dosage form, 
or quantity, or other errors as determined by the pharmacy. 
Data was collected for a minimum of 50 prescriptions per day 
for 15 days for a minimum total of 750 prescriptions per 
pharmacy (Figure 1). 
 
Once TPV was implemented, to assess the accuracy rate of the 
Validated Pharmacy Technician, a prescription was filled by a 
pharmacy technician, then the product was verified by a 
Validated Pharmacy Technician, and the product was then 
verified again by a pharmacist (Figure 2). Validated Pharmacy 
Technicians and pharmacist interns were not able to serve as 
the second product verification during daily quality assurance 
audits of another Validated Pharmacy Technician in accordance 
with the approved pilot procedures.22 
 
A pharmacist audited a minimum of five percent of the total 
number of prescriptions that were product verified by each 
Validated Pharmacy Technician each day. The quantity of data 
collected - five percent daily - was chosen to align with quality 
assurance measures required by the Wisconsin Pharmacy 
Examining Board.23 For example, a technician completed the 
product verification of 100 prescriptions during the day. The 
pharmacist audited 5 of those prescriptions to determine if the 
Validated Pharmacy Technician correctly completed the 
product verification. Data was collected on product verification 
errors involving incorrect drug, dose, dosage form, or quantity, 
or other errors as determined by the pharmacy. 
 
On a monthly basis, aggregate data for each pharmacy was 
collected. This included the total number of prescriptions that 
were filled at the pharmacy, the total number of prescriptions 
that were product verified by a Validated Pharmacy Technician, 
the total number of product verifications completed by 
Validated Pharmacy Technicians which were audited by a 
pharmacist, the total number of errors identified by a 
pharmacist during the audits, and the specific errors identified. 
Once submitted to the research team, the rate of verification 
errors was calculated for each pharmacy individually and for all 
of the pharmacies combined. 
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Figure 1. Process to Establish the Accuracy of Pharmacists at Completing the Product Verification (Baseline)
 
 
 
 
 
Figure 2. Process to Establish the Accuracy of Validated Pharmacy Technicians at Completing the Product Verification 
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Assess Effect of TPV on Pharmacist Workday Composition and 
Provision of Patient Care  
The impact of technician product verification in community 
pharmacies in Wisconsin in facilitating community pharmacist-
provided services was assessed by measuring how pharmacists’ 
time was allocated prior to and post-technician product 
verification implementation. 
 
Pharmacists self-reported the activities they completed during 
the workday at both baseline and after technician product 
verification implementation. Baseline data was collected for a 
minimum of 15 consecutive days to account for fluctuations 
based on day of the week, vacation, and other absences. Post-
technician product verification implementation, pharmacists 
continued to self-report the activities they completed during 
each day for which technician product verification was used. 
Time allocation data was not collected for pharmacist interns, 
as they do not complete managerial activities, which must be 
accounted for to provide an accurate depiction of the effect of 
technician product verification on pharmacist time. 
 
Results 
Of the 16 pharmacies that participated, one pharmacy 
withdrew from the pilot due to staffing turnover and two 
pharmacies (within the same organization) withdrew due to a 
new computer software system that did not permit a fluid 
workflow for technician product verification. The study 
concluded with 13 pharmacies submitting data: six chain 
pharmacies, five outpatient health-system pharmacies, and five 
independent pharmacies. 
 
Effect of TPV on Patient Safety 
During the study period, 12,891 pharmacist-verified 
prescriptions (baseline) and 27,447 Validated Pharmacy 
Technician-verified prescriptions were audited for accuracy. 
The aggregate verification error rate for pharmacist-verified 
prescriptions was 0.16% and 0.01% for technician verified 
prescriptions. The mean rate was significantly less for Validated 
Pharmacy Technician-verified prescriptions than for 
pharmacist-verified prescriptions (0.19 ± 0.174 % vs 0.03 ± 
0.089 %, p=0.020) (Figure 3).  
 
Effect of TPV on Pharmacist Workday Composition and 
Provision of Patient Care 
Only one pharmacy consistently completed data collection for 
ten months of the intervention period. The range of months 
collected by the other pharmacies ranged from one month for 
three of the pharmacies to seven months for the remaining 
pharmacy. The mean number of months collected was 3.77 and 
the median was 4. The number of pharmacies reporting in a 
month ranged from one pharmacy in two months to ten 
pharmacies in one month. The mean number of pharmacies 
reporting per month was 4.9 and the median was 4.5. In 
addition to an inconsistent number of pharmacies reporting 
pharmacists’ workday composition each month, examination of 
the amount of time submitted for many of the months 
indicated that not all pharmacist activity was being recorded, as 
there was a significant difference between the number of hours 
reported and the expected number of hours based on staffing 
levels. Due to incomplete and inconsistent data reporting, no 
aggregate analysis of pharmacist workday composition was 
performed.  
 
As stated above, one pharmacy did consistently report 
pharmacist workday composition at baseline for ten months 
during the active intervention period. Comparing the 
pharmacist activity times with staffing at this site also indicated 
that most of the pharmacists’ activities were being reported. 
For this pharmacy, during baseline determination, 25.9% of 
pharmacists’ time was spent in patient care activities, 12.35% 
of the time in management activities, and 61.73% in dispensing 
activities. Over the ten months of technician product 
verification, the amount of time spent in patient care activities 
was 58.62%, while 22.96% of time was spent in management 
activities, 4.73% in other activities, and 13.70% in dispensing 
activities.  
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Figure 3. Accuracy of Completing the Product Verification Results 
 
 
 
Discussion 
Impact of TPV on Patient Safety 
Pharmacists demonstrated a very low baseline rate of errors 
during product verification. The rates were similar to a recent 
study in Iowa that had examined the verification error rate in 
community pharmacies (0.19 ± 0.174 % vs 0.48 ± 0.23 %).24 In 
the Wisconsin study, once technician product verification was 
implemented, there was a significant decrease in the rate of 
verification errors (0.19 ± 0.174 % vs 0.03 ± 0.089 %, p=0.020). 
The rate of verification errors in technician verified 
prescriptions in the current study was lower than in the Iowa 
study mentioned earlier 0.03 ± 0.089 %. These findings suggest 
TPV can be safely performed by pharmacy technicians with 
specific training on TPV as part of an optimizing care model.  
 
Impact of TPV on Pharmacist Workday Composition and 
Provision of Patient Care 
For the pharmacy that reported consistently during both the 
baseline and intervention periods of the study, when TPV was 
initiated in the pharmacy, the amount of time pharmacists 
reported providing patient care services more than doubled 
from 25.9% to 58.62% while dispensing activities decreased 
from 61.73% to 13.7% of the pharmacists’ time. This is similar 
to what was seen in the recent Iowa study that had examined 
the effect of the initiation of technician product verification on 
pharmacists’ workday composition and provision of patient 
care. In the Iowa study, the time pharmacists spent dispensing 
decreased by 29.7% while time spent providing patient care 
increased by 26.4%.  
 
The results of our Wisconsin pilot, in the context of research to 
date, indicate that using technician product verification can 
greatly decrease the amount of time pharmacists spend on 
dispensing activities that do not require clinical judgement, 
with that time being redirected to increase pharmacists’ 
capacity to provide patient care activities and deploy their 
clinical expertise to improve care.  
 
Challenges / Lessons Learned 
Pharmacy Technician Validation Process 
One challenge to efficient technician product verification 
implementation in this pilot was the amount of time required 
to complete the product verification of 1,000 prescriptions that 
were then audited by a pharmacist for accuracy. The pharmacy 
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technician was required to be 99.8% accurate to become a 
Validated Pharmacy Technician. A pharmacy technician could 
not complete the product verification of a prescription they 
filled.25   
 
Therefore, staffing must be adequate to allow another 
pharmacy technician to be filling simultaneously, or pre-filling 
prescriptions, for the pharmacy technician being validated. 
Pharmacies found it challenging to remove a staff member 
being validated from their workflow to complete this validation 
process. Because a pharmacist was required to complete the 
second verification, this eliminated the possibility of utilizing a 
pharmacist intern as another staff member to complete the 
process. In pharmacies that were attempting to validate more 
than one pharmacy technician, this was an even larger 
challenge. Further, in pharmacies with small prescription 
volumes, this process took weeks to months to validate one 
pharmacy technician. In other studies, the requirements for the 
verification technicians were based on overall and site-specific 
experience as a pharmacy technician. 
 
Based on this experience, the research team would suggest that 
future evaluations of technician product verification consider 
other performance-based methods and site-specific factors for 
technician validation and seek to facilitate an efficient 
validation process for technicians while maintaining safeguards 
for patient safety. This helps ensure that the impact of 
technician product verification, which is designed to improve 
efficiencies and advance pharmacist-provided care for patients, 
is not undermined due to cumbersome, lengthy validation 
requirements and processes.  
 
Computer Software Capabilities and Refinements 
Participating pharmacies experienced difficulties delegating 
product verification privileges to Validated Pharmacy 
Technicians due to lacking capabilities in their computer 
systems. Validated Pharmacy Technicians having such abilities 
in their computer programs was not a requirement of the pilot 
or the study, but the Pharmacy Society of Wisconsin found it 
essential to gaining trust and support from organizational 
leadership, pharmacists, and pharmacy technicians. 
 
Changes in the computer system required engagement from 
technology departments and organizational leadership to 
create a new Validated Pharmacy Technician category within 
the software program. Because each pharmacy organization 
may use a different computer system, peer-to-peer sharing 
could not be leveraged. However, once a Validated Pharmacy 
Technician category was created in the computer system, the 
pharmacists were able to pull technician product verification 
reports quickly instead of manually collecting data. 
 
The research team suggests that future evaluations of 
technician product verification prioritize the ability for 
technicians to perform TPV in workflow via new category 
designation in the pharmacy software system. 
Staffing Changes Impact on Pilot Requirements 
Many pharmacies in this study faced staffing turnover. In 
accordance with pilot requirements, Validated Pharmacy 
Technicians were required to have “a minimum of 2000 hours 
of experience as a pharmacy technician or completion of an 
accredited pharmacy technician training program.” Further, 
they were required to have “at least 6 months of employment 
as a pharmacy technician at any pharmacy within the 
organization.”26 Staffing turnover occurred with Validated 
Pharmacy Technicians, occasionally causing the challenge of 
finding a qualifying replacement. The pilot requirement made it 
difficult, if not impossible, to replace any Validated Pharmacy 
Technician who left a pharmacy during the course of the study. 
Often a Validated Pharmacy Technician had to fill in for another 
staff member, and technician product verification was delayed 
until the staff was once again at full capacity.  
 
A lesson learned was that once the pharmacy begins to utilize 
technician product verification, the Validated Pharmacy 
Technician staffing is critical. And from prior literature and 
experience, the impact of Technician Product Verification is 
maximized when the new workflow model is implemented 
consistently over time. 27Not having a Validated Pharmacy 
Technician requires the pharmacy to revert back to a traditional 
model of pharmacist verification of prescriptions with resulting 
implications for the pharmacists’ ability to optimize patient care 
services. Therefore, to minimize disruptions, the study team 
recommends that pharmacies implementing TPV include 
training and validating of multiple qualifying technicians at a 
site, and rotating verification duties, so that multiple 
technicians are equipped to perform product verification if 
staffing challenges are encountered.  
 
Limitations 
Due to logistical issues arising from the implementation of 
technician product verification, data collection on the 
pharmacists’ workday composition was limited. This precluded 
a robust statistical analysis of the effects of initiating technician 
product verification on redirection of pharmacist time. While 
the positive changes seen in one pharmacy were similar to 
those seen in another similar study in Iowa, these changes may 
not be reflective of the experience in all of the pharmacies in 
the pilot. As self-reported data was used, the potential for social 
desirability bias exists.  
 
Pharmacists expressed concern with documenting their time 
throughout the day as it is time-consuming, disruptive to their 
workflow, and detracts from patient care. For future 
evaluations of Technician Product Verification, the study team 
recommends implementing a standardized process to 
consistently track pharmacist time and address barriers to 
measure and report pharmacist time on an ongoing basis. The 
research may not be applicable to pharmacies subject to 
different regulatory requirements.  
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Conclusions 
This study suggests technician product verification in the 
community setting can maintain patient safety. The results of 
this study are similar to previous studies regarding the abilities 
of pharmacy technicians to verify the product in a filled 
prescription. In this study, Validated Pharmacy Technicians 
were shown to be more accurate than pharmacists in 
performing product verification. This suggests that technician 
product verification is safe for completing the common and 
time intensive task of product verification, which is currently 
performed by pharmacists as required by law in most states.  
 
The ability to delegate the product verification task holds the 
potential to free up pharmacist time for increased direct patient 
care. Increasing direct patient care by pharmacists in 
community pharmacies may have significant implications for 
improving patient outcomes and pharmacy quality. Due to 
several issues mentioned earlier, a large-scale assessment of 
the effect of this transfer on pharmacists’ ability to provide 
services was not possible in this pilot. One pharmacy was able 
to complete the duration of the study using technician product 
verification and the results in this pharmacy were similar to the 
results found in previous research at a similar time after 
implementation of technician product verification. 
 
This study is also a reminder of the challenges that can arise 
when performing practice-based research, including challenges 
that lead to delays in implementation and inconsistent and 
incomplete data collection. This reinforces the importance of a 
coordinated effort to begin research when participating sites 
are ready, and for continued contact with the participating 
pharmacies to help ensure full engagement and recordkeeping.  
Future Practice 
The results of this study can be used to support efforts to 
expand technician product verification in Wisconsin and across 
the country. Since the study period, Wisconsin has codified the 
pilot language into Wisconsin regulations to make TPV 
permanent in the state.28 This research adds to the rapidly 
expanding amount of information being generated by other 
states’ TPV pilot programs, reinforcing the safety and 
effectiveness of the process to optimize pharmacist-provided 
patient care. This study has potentially significant implications 
for optimizing community pharmacy-based patient care by 
improving the utilization of resources. The results of this study 
closely replicate previous, similar findings that technician 
product verification allows a repositioning of pharmacists to 
provide more patient care without compromising patient 
safety.  
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